Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series

Background: Cefiderocol is a novel parenteral siderophore cephalosporin, demonstrating enhanced activity against multidrug-resistant (MDR) Gram-negative bacteria and difficult-to-treat Acinetobacter baumannii (DTR-AB). Plasma-free trough concentration (fC(trough)) over the minimum inhibitory concent...

Descripción completa

Detalles Bibliográficos
Autores principales: Mornese Pinna, Simone, Corcione, Silvia, De Nicolò, Amedeo, Montrucchio, Giorgia, Scabini, Silvia, Vita, Davide, De Benedetto, Ilaria, Lupia, Tommaso, Mula, Jacopo, Di Perri, Giovanni, D’Avolio, Antonio, De Rosa, Francesco Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774561/
https://www.ncbi.nlm.nih.gov/pubmed/36551485
http://dx.doi.org/10.3390/antibiotics11121830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774561/
https://www.ncbi.nlm.nih.gov/pubmed/36551485
http://dx.doi.org/10.3390/antibiotics11121830

Ejemplares similares